BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: A population-based study in central Italy

Laura Ottini, Piera Rizzolo, Ines Zanna, Mario Falchetti, Giovanna Masala, Ketty Ceccarelli, Vania Vezzosi, Alberto Gulino, Giuseppe Giannini, Simonetta Bianchi, Francesco Sera, Domenico Palli

Research output: Contribution to journalArticle

Abstract

Background Male breast cancer (MBC) is a rare and scarcely investigated disease. The strongest genetic risk factor for MBC is represented by inherited BRCA2 mutations, whereas the association between MBC and BRCA1 mutations is less clear. MBC appears to be biologically similar to breast cancer in females, however the phenotypic haracteristics of BRCA1/2-related MBCs are not yet well elucidated. Objective To investigate the genetic and phenotypic characteristics of MBC in a large and wellcharacterized population-based series of 108 MBCs from Tuscany (Central Italy) and to evaluate associations between BRCA1/BRCA2 mutation status and clinical-pathological features including breast/ovarian cancer first-degree family history, tumor histology and grade, proliferative activity, estrogen/progesterone receptors (ER/PR) and epidermal growth factor receptor 2 (HER2) expression. Results BRCA1/BRCA2 mutations were identified in ten MBCs, in particular, two cases (1.9%) carried BRCA1 and eight cases (7.4%) carried BRCA2 mutations. The same BRCA1 mutation (3347delAG) was detected in two unrelated MBC cases. Three novel BRCA2 pathogenic mutations were found. Statistically significant associations emerged between BRCA2-related tumors and absence of PR expression (P = 0.008), HER2 over-expression (P = 0.002) and high tumor grade (P = 0.005). Conclusions Here, we (i) reported that in our population about 9% of MBC cases are accounted for by BRCA1/BRCA2 mutations; (ii) enlarged the BRCA2 mutational spectrum and (iii) characterized a specific phenotype associated with BRCA2-related MBCs suggestive of aggressive behavior. Overall, our results may have important implications on clinical management for this rare disease.

Original languageEnglish
Pages (from-to)577-586
Number of pages10
JournalBreast Cancer Research and Treatment
Volume116
Issue number3
DOIs
Publication statusPublished - Aug 2009

Fingerprint

Male Breast Neoplasms
Italy
Mutation
Population
Breast Neoplasms
Neoplasms
Progesterone Receptors
Rare Diseases
Epidermal Growth Factor Receptor
Estrogen Receptors
Ovarian Neoplasms
Histology
Phenotype

Keywords

  • BRCA1
  • BRCA2 Germ-line mutations
  • Clinical-pathologic features
  • Male breast cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany : A population-based study in central Italy. / Ottini, Laura; Rizzolo, Piera; Zanna, Ines; Falchetti, Mario; Masala, Giovanna; Ceccarelli, Ketty; Vezzosi, Vania; Gulino, Alberto; Giannini, Giuseppe; Bianchi, Simonetta; Sera, Francesco; Palli, Domenico.

In: Breast Cancer Research and Treatment, Vol. 116, No. 3, 08.2009, p. 577-586.

Research output: Contribution to journalArticle

Ottini, L, Rizzolo, P, Zanna, I, Falchetti, M, Masala, G, Ceccarelli, K, Vezzosi, V, Gulino, A, Giannini, G, Bianchi, S, Sera, F & Palli, D 2009, 'BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: A population-based study in central Italy', Breast Cancer Research and Treatment, vol. 116, no. 3, pp. 577-586. https://doi.org/10.1007/s10549-008-0194-z
Ottini, Laura ; Rizzolo, Piera ; Zanna, Ines ; Falchetti, Mario ; Masala, Giovanna ; Ceccarelli, Ketty ; Vezzosi, Vania ; Gulino, Alberto ; Giannini, Giuseppe ; Bianchi, Simonetta ; Sera, Francesco ; Palli, Domenico. / BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany : A population-based study in central Italy. In: Breast Cancer Research and Treatment. 2009 ; Vol. 116, No. 3. pp. 577-586.
@article{a864dcbb6a4e43888e0837a6b9adb3ad,
title = "BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: A population-based study in central Italy",
abstract = "Background Male breast cancer (MBC) is a rare and scarcely investigated disease. The strongest genetic risk factor for MBC is represented by inherited BRCA2 mutations, whereas the association between MBC and BRCA1 mutations is less clear. MBC appears to be biologically similar to breast cancer in females, however the phenotypic haracteristics of BRCA1/2-related MBCs are not yet well elucidated. Objective To investigate the genetic and phenotypic characteristics of MBC in a large and wellcharacterized population-based series of 108 MBCs from Tuscany (Central Italy) and to evaluate associations between BRCA1/BRCA2 mutation status and clinical-pathological features including breast/ovarian cancer first-degree family history, tumor histology and grade, proliferative activity, estrogen/progesterone receptors (ER/PR) and epidermal growth factor receptor 2 (HER2) expression. Results BRCA1/BRCA2 mutations were identified in ten MBCs, in particular, two cases (1.9{\%}) carried BRCA1 and eight cases (7.4{\%}) carried BRCA2 mutations. The same BRCA1 mutation (3347delAG) was detected in two unrelated MBC cases. Three novel BRCA2 pathogenic mutations were found. Statistically significant associations emerged between BRCA2-related tumors and absence of PR expression (P = 0.008), HER2 over-expression (P = 0.002) and high tumor grade (P = 0.005). Conclusions Here, we (i) reported that in our population about 9{\%} of MBC cases are accounted for by BRCA1/BRCA2 mutations; (ii) enlarged the BRCA2 mutational spectrum and (iii) characterized a specific phenotype associated with BRCA2-related MBCs suggestive of aggressive behavior. Overall, our results may have important implications on clinical management for this rare disease.",
keywords = "BRCA1, BRCA2 Germ-line mutations, Clinical-pathologic features, Male breast cancer",
author = "Laura Ottini and Piera Rizzolo and Ines Zanna and Mario Falchetti and Giovanna Masala and Ketty Ceccarelli and Vania Vezzosi and Alberto Gulino and Giuseppe Giannini and Simonetta Bianchi and Francesco Sera and Domenico Palli",
year = "2009",
month = "8",
doi = "10.1007/s10549-008-0194-z",
language = "English",
volume = "116",
pages = "577--586",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York LLC",
number = "3",

}

TY - JOUR

T1 - BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany

T2 - A population-based study in central Italy

AU - Ottini, Laura

AU - Rizzolo, Piera

AU - Zanna, Ines

AU - Falchetti, Mario

AU - Masala, Giovanna

AU - Ceccarelli, Ketty

AU - Vezzosi, Vania

AU - Gulino, Alberto

AU - Giannini, Giuseppe

AU - Bianchi, Simonetta

AU - Sera, Francesco

AU - Palli, Domenico

PY - 2009/8

Y1 - 2009/8

N2 - Background Male breast cancer (MBC) is a rare and scarcely investigated disease. The strongest genetic risk factor for MBC is represented by inherited BRCA2 mutations, whereas the association between MBC and BRCA1 mutations is less clear. MBC appears to be biologically similar to breast cancer in females, however the phenotypic haracteristics of BRCA1/2-related MBCs are not yet well elucidated. Objective To investigate the genetic and phenotypic characteristics of MBC in a large and wellcharacterized population-based series of 108 MBCs from Tuscany (Central Italy) and to evaluate associations between BRCA1/BRCA2 mutation status and clinical-pathological features including breast/ovarian cancer first-degree family history, tumor histology and grade, proliferative activity, estrogen/progesterone receptors (ER/PR) and epidermal growth factor receptor 2 (HER2) expression. Results BRCA1/BRCA2 mutations were identified in ten MBCs, in particular, two cases (1.9%) carried BRCA1 and eight cases (7.4%) carried BRCA2 mutations. The same BRCA1 mutation (3347delAG) was detected in two unrelated MBC cases. Three novel BRCA2 pathogenic mutations were found. Statistically significant associations emerged between BRCA2-related tumors and absence of PR expression (P = 0.008), HER2 over-expression (P = 0.002) and high tumor grade (P = 0.005). Conclusions Here, we (i) reported that in our population about 9% of MBC cases are accounted for by BRCA1/BRCA2 mutations; (ii) enlarged the BRCA2 mutational spectrum and (iii) characterized a specific phenotype associated with BRCA2-related MBCs suggestive of aggressive behavior. Overall, our results may have important implications on clinical management for this rare disease.

AB - Background Male breast cancer (MBC) is a rare and scarcely investigated disease. The strongest genetic risk factor for MBC is represented by inherited BRCA2 mutations, whereas the association between MBC and BRCA1 mutations is less clear. MBC appears to be biologically similar to breast cancer in females, however the phenotypic haracteristics of BRCA1/2-related MBCs are not yet well elucidated. Objective To investigate the genetic and phenotypic characteristics of MBC in a large and wellcharacterized population-based series of 108 MBCs from Tuscany (Central Italy) and to evaluate associations between BRCA1/BRCA2 mutation status and clinical-pathological features including breast/ovarian cancer first-degree family history, tumor histology and grade, proliferative activity, estrogen/progesterone receptors (ER/PR) and epidermal growth factor receptor 2 (HER2) expression. Results BRCA1/BRCA2 mutations were identified in ten MBCs, in particular, two cases (1.9%) carried BRCA1 and eight cases (7.4%) carried BRCA2 mutations. The same BRCA1 mutation (3347delAG) was detected in two unrelated MBC cases. Three novel BRCA2 pathogenic mutations were found. Statistically significant associations emerged between BRCA2-related tumors and absence of PR expression (P = 0.008), HER2 over-expression (P = 0.002) and high tumor grade (P = 0.005). Conclusions Here, we (i) reported that in our population about 9% of MBC cases are accounted for by BRCA1/BRCA2 mutations; (ii) enlarged the BRCA2 mutational spectrum and (iii) characterized a specific phenotype associated with BRCA2-related MBCs suggestive of aggressive behavior. Overall, our results may have important implications on clinical management for this rare disease.

KW - BRCA1

KW - BRCA2 Germ-line mutations

KW - Clinical-pathologic features

KW - Male breast cancer

UR - http://www.scopus.com/inward/record.url?scp=70349581484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349581484&partnerID=8YFLogxK

U2 - 10.1007/s10549-008-0194-z

DO - 10.1007/s10549-008-0194-z

M3 - Article

C2 - 18819001

AN - SCOPUS:70349581484

VL - 116

SP - 577

EP - 586

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -